Dogwood Therapeutics Secures License from Serpin Pharma to Develop and Commercialize SP16 as a Treatment for Cancer Related Pain in an All-Stock Transaction

Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a clinical-stage biotechnology company developing new medicines to treat pain and neuropathy, recently announced that in an all-stock transaction, it has secured a royalty free, global license to develop Serpin Pharma’s intravenous (IV) formulation of SP16 to manage cancer related pain (CRP) including a broad range…

Navigating Global Growth Humanizing the Cloud-Based Law Firm, ABA Podcast

In an American Bar Association podcast hosted by Terrell Turner, CPA, Rimon Managing Partner Juan Zúñiga shares insights into building a distributed law firm, maintaining core values, and strategically planning for future growth. Juan discusses strategic growth plans,  Rimon as an alternative to big law for talented, entrepreneurial attorneys, and the importance of fostering collaborative,…

Rimon attorneys asked to serve as counsel to the Committee in the Publishers Clearing House bankruptcy proceedings

We are pleased to announce that Rimon attorneys, Brian Powers, Ken Silverman, Ronald Friedman, Haley Trust, and Courtney Roman have been asked to serve as counsel to the Committee in the Publishers Clearing House bankruptcy proceedings. Publishers Clearing House, a renowned sweepstakes company, filed for bankruptcy protection in New York last month. Publishers Clearing House…